Skip to content

All episodes

Movement Disorders Journal Podcasts 2012-2015, 577 episodes. Page 1 of 6.

#
Title
1

Progressive Retinal Structure Abnormalities in Multiple System Atrophy

2

Multiple Resting-State Networks Are Associated With Tremors and Cognitive Features in Essential Tremor

3

The Motor Inhibition System in Parkinson’s Disease With Levodopa-Induced Dyskinesias

4

Volume 30 Issue 14 (2015)

5

Factor Analysis of the Hospital Anxiety and Depression Scale Among a Huntington’s Disease Population

6

Functional Assessment and Quality of Life in Essential Tremor With Bilateral or Unilateral DBS and Focused Ultrasound Thalamotomy

7

Is Dominant-Side Onset Associated With a Better Motor Compensation in Parkinson’s Disease?

8

Cerebral Perfusion and Cortical Thickness Indicate Cortical Involvement in Mild Parkinson’s Disease

9

Clinicopathological Characteristics of Freezing of Gait in Autopsy-Confirmed Parkinson’s Disease

10

Diffusion Imaging of Nigral Alterations in Early Parkinson’s Disease With Dopaminergic Deficits

11

Volume 30 Issue 13 (2015)

12

Sleep aspects on video-polysomnography in LRRK2 mutation carriers

13

The Severity and Pattern of Autonomic Dysfunction in Idiopathic Rapid Eye Movement Sleep Behavior Disorder

14

Light pigmentation phenotype is correlated with increased substantia nigra echogenicity

15

Rasagiline for the symptomatic treatment of fatigue in Parkinson's disease

16

REM sleep behavior disorder, as assessed by questionnaire, in G2019S LRRK2 mutation PD and carriers

17

Region-Specific Alterations of Matrix Metalloproteinase Activity in Multiple System Atrophy

18

Neuropathology and Cellular Pathogenesis of Spinocerebellar Ataxia Type 12

19

Loss of EEG Network Efficiency Is Related to Cognitive Impairment in Dementia With Lewy Bodies

20

Altered brain network centrality in depressed Parkinson's disease patients

21

Delineating nonmotor symptoms in early Parkinson's disease and first-degree relatives

22

Subthalamic deep brain stimulation differently alters striatal dopaminergic receptor levels in rats

23

Eltoprazine prevents levodopa-induced dyskinesias by reducing striatal glutamate and direct pathway activity

24

Volume 30 Issue 12 (2015)

25

Premotor–motor excitability is altered in dopa-responsive dystonia

26

Cerebellar transcranial direct current stimulation in patients with ataxia: A double-blind, randomized, sham-controlled study

27

A randomized, double-blind phase I/IIa study of intranasal glutathione in Parkinson's disease

28

NBI-98854, a selective monoamine transport inhibitor for the treatment of tardive dyskinesia: A randomized, double-blind, placebo-controlled study

29

Distinctive distribution of phospho-alpha-synuclein in dermal nerves in multiple system atrophy

30

A novel retinal biomarker for Parkinson's disease: Quantifying the foveal pit with optical coherence tomography

31

Essential and aging-related tremor: Differences of central control

32

Multivariate prediction of motor diagnosis in Huntington's disease: 12 years of PREDICT-HD

33

Exercise improves cognition in Parkinson's disease: The PRET-PD randomized, clinical trial

34

Plasma apolipoprotein A1 associates with age at onset and motor severity in early Parkinson's disease patients

35

Lysosomal-associated membrane protein 2 isoforms are differentially affected in early Parkinson's disease

36

Handling missing values in the MDS-UPDRS

37

King's Parkinson's disease pain scale, the first scale for pain in PD: An international validation

38

Volume 30 Issue 10 (2015)

39

Ethyl-eicosapentaenoic acid treatment in Huntington's disease: A placebo-controlled clinical trial

40

Quantitative assessment of brain iron by R2* relaxometry in patients with cervical dystonia

41

Uncoupling of dopaminergic and subthalamic stimulation: Life-threatening DBS withdrawal syndrome

42

Probable RBD and association with neurodegenerative disease markers: A population-based study

43

REM sleep behavior disorder and neuropathology in Parkinson's disease

44

Functional connectivity changes related to cognitive and motor performance in spinocerebellar ataxia type 2

45

Longitudinal study of the substantia nigra in Parkinson's disease: A high-field 1H-MR spectroscopy imaging study

46

Appendectomy may delay Parkinson's disease Onset

47

Correlates of excessive daytime sleepiness in de novo Parkinson's disease: A case control study

48

Modifications of resting state networks in spinocerebellar ataxia type 2

49

Levodopa Is a Double-Edged Sword for Balance and Gait in People With Parkinson's Disease

50

Colonic bacterial composition in Parkinson's disease

51

Zonisamide improves wearing-off in Parkinson's disease: A randomized, double-blind study

52

Patterns of linkage disequilibrium at PARK16 may explain variances in genetic association studies

53

Tremor in the elderly: Essential and aging-related tremor

54

Global cognitive scores do not predict outcome after subthalamic nucleus deep brain stimulation

55

Volume 30 Issue 9 (2015)

56

Reproducibility of a Parkinsonism-related metabolic brain network in non-human primates: A descriptive pilot study with FDG PET

57

A unique retinal epitheliopathy is associated with amyotrophic lateral sclerosis/Parkinsonism-Dementia complex of Guam

58

Olfactory Dysfunction Evaluation Is Not Affected by Comorbid Depression in Parkinson's Disease

59

Sensorimotor processing for balance in spinocerebellar ataxia type 6

60

Dyskinesia detection and monitoring by a single sensor in patients with Parkinson's disease

61

Distinct patterns of brain activity in progressive supranuclear palsy and Parkinson's disease

62

Default mode network links to visual hallucinations: A comparison between Parkinson's disease and multiple system atrophy

63

Gastroretentive carbidopa/levodopa, DM-1992, for the treatment of advanced Parkinson's disease

64

Diffusion tensor imaging of the nigrostriatal fibers in Parkinson's disease

65

Objective assessment of postural stability in Parkinson's disease using mobile technology

66

GDNF gene is associated with Tourette syndrome in a family study

67

T1ρ imaging in premanifest Huntington's disease reveals changes associated with disease progression

68

Volume 30 Issue 8 (2015)

69

Freezing of gait in Parkinson's disease is related to impaired motor switching during stepping

70

Transcranial magnetic stimulation follow-up study in early Parkinson's disease: A decline in compensation with disease progression?

71

High nigral iron deposition in LRRK2 and Parkin mutation carriers using R2* relaxometry

72

Dorsolateral nigral hyperintensity on 3.0T susceptibility-weighted imaging in neurodegenerative Parkinsonism

73

In-patient multidisciplinary rehabilitation for Parkinson's disease: A randomized controlled trial

74

Dopaminergic regulation of olfactory type G-protein α subunit expression in the striatum

75

Manganese transport disorder: Novel SLC30A10 mutations and early phenotypes

76

Volume 30 Issue 7 (2015)

77

Skin biopsy and I-123 MIBG scintigraphy findings in idiopathic Parkinson's disease and parkinsonism: A comparative study

78

Pallidal activity in myoclonus dystonia correlates with motor signs

79

Plasma Oligomeric Alpha-Synuclein Is Associated With Glucocerebrosidase Activity in Gaucher Disease

80

Novel candidate blood-based transcriptional biomarkers of Machado-Joseph disease

81

Nonmotor symptoms in healthy Ashkenazi Jewish carriers of the G2019S mutation in the LRRK2 gene

82

Nonmotor Symptoms in Subjects Without Evidence of Dopaminergic Deficits

83

Minimal change multiple system atrophy: An aggressive variant?

84

Substantia nigra neuromelanin-MR imaging differentiates essential tremor from Parkinson's disease

85

Automated Neuromelanin Imaging as a Diagnostic Biomarker for Parkinson's Disease

86

Amyloid deposition in Parkinson's disease and cognitive impairment: A systematic review

87

Cerebrospinal fluid Aβ42 levels and APP processing pathway genes in Parkinson's disease

88

Cognitive performance and neuropsychiatric symptoms in early, untreated Parkinson's disease

89

Rivastigmine for mild cognitive impairment in Parkinson disease: A placebo-controlled study

90

Volume 30, Issue 6 (2015)

91

Olfactory dysfunction in Parkinson's disease: Positive effect of cigarette smoking

92

Platelet mitochondrial activity and pesticide exposure in early Parkinson's disease

93

Diminished event-related cortical arousals and altered heart rate response in Parkinson's disease

94

Impact of Parkinson's disease risk loci on age at onset

95

Genetic risk and age in Parkinson's disease: Continuum not stratum

96

Mosaic dominant TUBB4A mutation in an inbred family with complicated hereditary spastic paraplegia

97

Antisaccades and executive dysfunction in early drug-naive Parkinson's disease: The discovery study

98

Somatosensory temporal discrimination in essential tremor and isolated head and voice tremors

99

Low-variance RNAs identify Parkinson's disease molecular signature in blood

100

H-ABC syndrome and DYT4: Variable expressivity or pleiotropy of TUBB4 mutations?